FDA Recommends Withdrawing Avastin’s Approval for Breast Cancer

Published December 18, 2010

FDA Recommends Withdrawing Avastin’s Approval for Breast Cancer
The Food and Drug Administration (FDA) is recommending that the approval of Avastin for the treatment of breast cancer be revoked. The move comes after the agency reviewed the results of four clinical trials of the drug, and determined that … Continue reading →
Read more on Wellness

PSA Test Better Predicts Cancer In Men Taking Prostate-Shrinking Drug
The PSA screening test for prostate cancer is not perfect. It can indicate cancer when none is present and miss life-threatening tumors. But a new study suggests the test is more reliable in men taking dutasteride (Avodart®), a drug widely prescribed to shrink an enlarged prostate gland. Dutasteride lowers PSA levels by about half within six months…
Read more on Medical News Today

Biotech Stocks: Neuralstem, Impax in drug-sector spotlight
Shares of Neuralstem climb on news that U.S. regulators gave the company a green light to begin testing its new antidepressant drug.
Read more on Market Watch